CVS Health exceeded first-quarter earnings and revenue expectations, driven by strong performance across all business segments including its insurer Aetna, retail pharmacy, and health services. The company raised its 2026 profit forecast to $7.30-$7.50 per share and revenue guidance to at least $405 billion, up from previous estimates. Improvements in Aetna's insurance business, including better management of medical costs and a lower medical benefit ratio, contributed to the positive results. CVS's ongoing turnaround efforts, such as cost cuts, store closures, and leadership changes, continue to show progress, positioning the company well for future growth.
Aetna's latest survey shows U.S. healthcare providers' trust in payers increased to a score of 6.1 from 5.4, reflecting improved perceptions of payer reliability and communication. Providers highlight technology's role in reducing administrative task...
CVS Caremark announced a global settlement with the Federal Trade Commission (FTC) resolving all litigation related to rebate practices, pharmacy network contracting, and vertical integration. The agreement ends ongoing investigations and allows CVS ...
